Evaluation of Perirenal Fat as a Predictor of cT1a Renal Cortical Neoplasm Histopathology and Surgical Outcomes

被引:19
|
作者
Okhunov, Zhamshid [2 ]
Mues, Adam C. [3 ]
Kline, Myriam [5 ]
Haramis, Georgios [4 ]
Xu, Bin [2 ]
Mirabile, Gabriella [2 ]
Vira, Manish [2 ]
Landman, Jaime [1 ]
机构
[1] Univ Calif Irvine, Dept Urol, Orange, CA 92868 USA
[2] N Shore Long Isl Jewish Hlth Syst, Smith Inst Urol, New Hyde Pk, NY USA
[3] NYU, Dept Urol, New York, NY USA
[4] Columbia Univ, Med Ctr, Dept Urol, New York, NY USA
[5] N Shore LIJ Hlth Syst, Feinstein Inst Med Res, Biostat Unit, Manhasset, NY USA
关键词
HISTOLOGIC SUBTYPES; ADIPONECTIN LEVELS; CELL CARCINOMA; TUMOR LOCATION; CANCER; OBESITY; IMPACT; ACCUMULATION; NEPHRECTOMY; MASSES;
D O I
10.1089/end.2011.0599
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and Purpose: With the increasing detection of small renal cortical neoplasms (RCNs), the preoperative prediction of histopathology has become increasingly important. Because perirenal fat (PF) is known to be metabolically active, we evaluated PF as a predictor of renal tumor histopathology. Patients and Methods: We retrospectively evaluated patients who underwent laparoscopic nephron-sparing procedures for cT(1a) RCN at two institutions. PF was measured using the digital measuring tool function on standard imaging software, at the level of the renal hilum as the perpendicular distance between the posterior surface of the kidney and the external margin of the psoas muscle. The Mann-Whitney test and logistic regression were used to examine PF, selected demographic, clinical, and operative parameters, and their association with tumor histopathology. Results: Data from 250 patients were included in this study. There were 157 (63%) men and 93 (37%) women with a median body mass index (BMI) of 28 kg/m(2). Median tumor size was 2.4 cm, and the median PF distance was 12 mm. Significant correlations were noted between PF and sex and BMI. No significant correlations were found between PF and the operative parameters. Results of a multivariate logistic regression analysis revealed that PF (P < 0.01), age (P < 0.04), and tumor location (P < 0.04) were significant predictors of clear-cell renal-cell carcinoma (RCC) histopathology. Conclusions: In this study, PF, location of tumor, and age were significant predictors of clear-cell RCC histopathology. The correlation of PF and histopathology may be useful in preoperative decision-making and surgical planning in the management of small RCN.
引用
收藏
页码:911 / 916
页数:6
相关论文
共 25 条
  • [11] Contrast-enhanced CT immediately following percutaneous microwave ablation of cT1a renal cell carcinoma: Optimizing cancer outcomes
    Koebe, Samuel D.
    Curci, Nicole E.
    Caoili, Elaine M.
    Triche, Benjamin L.
    Dreyfuss, Leo D.
    Allen, Glenn O.
    Brace, Christopher L.
    Davenport, Matthew S.
    Abel, E. Jason
    Wells, Shane A.
    ABDOMINAL RADIOLOGY, 2022, 47 (08) : 2674 - 2680
  • [12] Comparison of perioperative outcomes of robot-assisted partial nephrectomy without renorrhaphy: Comparative outcomes of cT1a versus cT1b renal tumors
    Tohi, Yoichiro
    Murata, Shiori
    Makita, Noriyuki
    Suzuki, Issei
    Kubota, Masashi
    Sugino, Yoshio
    Inoue, Koji
    Kawakita, Mutsushi
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 (09) : 885 - 889
  • [13] Contrast-enhanced CT immediately following percutaneous microwave ablation of cT1a renal cell carcinoma: Optimizing cancer outcomes
    Samuel D. Koebe
    Nicole E. Curci
    Elaine M. Caoili
    Benjamin L. Triche
    Leo D. Dreyfuss
    Glenn O. Allen
    Christopher L. Brace
    Matthew S. Davenport
    E. Jason Abel
    Shane A. Wells
    Abdominal Radiology, 2022, 47 : 2674 - 2680
  • [14] Comparison of Long-term Outcomes for Young and Healthy Patients with cT1a and cT3a Renal Cell Carcinoma Treated with Partial Nephrectomy
    Tan, Wei Shen
    Koelker, Mara
    Campain, Nicholas
    Cole, Alexander P.
    Labban, Muhieddine
    Mossanen, Matthew
    Barod, Ravi
    Kibel, Adam S.
    Chang, Steven L.
    Bex, Axel
    Trinh, Quoc-Dien
    EUROPEAN UROLOGY FOCUS, 2023, 9 (02): : 333 - 335
  • [15] Comparative Analysis of Trifecta Outcomes in Robot-Assisted Partial Nephrectomy for cT1a Versus cT1b+Renal Tumours-a Single-Centre Study
    Dilip, Sunny Khanna
    Carbin, Danny Darlington
    Singh, Surendra
    Patil, Saurabh
    Ahluwalia, Puneet
    Gautam, Gagan
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2022, 13 (04) : 674 - 680
  • [16] Comparative Analysis of Trifecta Outcomes in Robot-Assisted Partial Nephrectomy for cT1a Versus cT1b + Renal Tumours—a Single-Centre Study
    Sunny Khanna Dilip
    Danny Darlington Carbin
    Surendra Singh
    Saurabh Patil
    Puneet Ahluwalia
    Gagan Gautam
    Indian Journal of Surgical Oncology, 2022, 13 : 674 - 680
  • [17] Fire and Ice: Clarifying Oncologic Outcomes Between Cryoablation and Heat-based Thermal Ablation in Patients With Larger cT1a Renal Tumors
    Roberson, Daniel S.
    Pierorazio, Phillip M.
    JOURNAL OF UROLOGY, 2023, 209 (01): : 21 - 22
  • [18] Perioperative and Oncological Outcomes of Percutaneous Radiofrequency Ablation versus Partial Nephrectomy for cT1a Renal Cancers: A Retrospective Study on Groups with Similar Clinical Characteristics
    Jasinski, Milosz
    Wisniewski, Przemyslaw
    Bielinska, Marta
    Siekiera, Jerzy
    Kamecki, Krzysztof
    Salagierski, Maciej
    CANCERS, 2024, 16 (08)
  • [19] cT1a Renal Masses Less Than 2 versus 2 cm or Greater Managed by Robotic Partial Nephrectomy: A Propensity Score Matched Comparison of Perioperative Outcomes
    Bertolo, Riccardo
    Garisto, Juan
    Dagenais, Julien
    Sagalovich, Daniel
    Agudelo, Jose
    Stein, Robert
    Fareed, Khaled
    Gao, Tianming
    Fergany, Amr
    Kaouk, Jihad
    JOURNAL OF UROLOGY, 2019, 201 (01): : 56 - 61
  • [20] The long-term outcomes of local tumor destruction versus partial nephrectomy for cT1a non-clear cell renal cell carcinoma and development of prognostic nomograms
    Qiu, Jianhui
    Deng, Ruiyi
    Zhao, Zihou
    Tian, Peidong
    Zhou, Jingcheng
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (03)